COMBINATION THERAPY OF ANTIBODY BINDING TO ANGIOPOIETIN 2 WITH ANTIBODY BINDING TO PROGRAMMED DEATH LIGAND 1

• 收藏
• 分享

专利权人:

Hoffmann-La Roche Inc.

发明人:

Frank Herting,Hans-Joachim Mueller

申请号：

US15788070

公开号：

US20180155431A1

申请日:

2017.10.19

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present invention relates to a combination therapy of an antibody specifically binding to Angiopoietin 2 (ANG-2), and an antibody specifically binding to VEGF with an antibody specifically binding to programmed death ligand 1 (PD-L1).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/